Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Tamsulosin (0.4mg) + Finasteride (5mg)
Therapeutic Category
General and OTC medicines, Urology
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹140/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Uriviga F MR Tablet is a combination therapy containing Tamsulosin (0.4mg) and Finasteride (5mg), specifically designed to manage the symptoms of benign prostatic hyperplasia (BPH). This medication offers dual-action relief by addressing the root causes of prostate enlargement and urinary discomfort:
This combination provides effective long-term management of BPH by relieving symptoms like frequent urination, difficulty in starting urination, and weak stream while simultaneously slowing prostate growth.
Possible side effects include headache, nausea, abdominal pain, and diarrhea. Long-term use may lead to vitamin B12 deficiency and bone fractures.
Ribziff 20 Injection is used for the treatment of gastroesophageal reflux disease (GERD), gastritis, and peptic ulcers. It is also used in combination therapy to eradicate Helicobacter pylori infection.
For intravenous use only. Administer under medical supervision, and do not exceed the recommended dose.
Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.
Composition : Pantoprazole (40mg) Injection
Composition : Esomeprazole (40mg) Injection
Composition : L-alanyl-L-glutamine (20gm)
Composition : Ondansetron (2mg) + Ranitidine (25mg)
Composition : Methylprednisolone (500mg)
Composition : Methylprednisolone (40mg)
Composition : Methylprednisolone (125mg)
Composition : Methylprednisolone (1000mg) Injection
Composition : Hydrocortisone (100mg) Injection
Composition : Hydroxyprogesterone (500mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Tamsulosin 0.4 mg + Finasteride 5 mg Tablet is a urology combination therapy primarily used for the management of Benign Prostatic Hyperplasia (BPH), commonly known as an enlarged prostate. Tamsulosin is an alpha-1 blocker that helps relax the muscles of the prostate and bladder neck, improving urine flow. Finasteride is a 5-alpha reductase inhibitor that helps reduce prostate size and slows disease progression. This combination provides both symptomatic relief and long-term disease management, making it a highly valuable product in the urology and men's health segment.
Medical distributors and wholesalers can benefit from consistent demand from urologists, physicians, and healthcare centers. Since BPH is a chronic condition affecting a large aging male population, patients often require long-term therapy, resulting in regular repeat prescriptions and sustained sales growth.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in urology, men's health, and chronic care segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from high chronic therapy adherence, increasing geriatric population, and strong specialist-driven demand, making it a stable, high-value, and repeat-prescription pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in urology and men's healthcare products can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the urology and chronic care segment.